General Electric mener, at GE Healthcare passer bedre ind i koncernen end en række analytikere og investorer gør.
Både analytikere og investorer har argumenteret for, at der kan skabes mere værdi ved at udskille som minimum dele af GE Healthcare fra GE-koncernen, men det kan de godt skyde en hvid pil efter.
"Vi har været helt klare omkring, at alle aspekter af vores healthcare er en del af vores portefølje. Der er ingen intention om at gøre noget i den retning," sagde John Flannery, adm. direktør for GE Healthcare, på den store Morgan Stanley-konference.
Clinical Trial Administrator - Zealand Pharma
Flow Cytometry Application Specialist Nordic South to Miltenyi Biotec
CMC Project Manager Drug Product
Associate Director/ Director Corporate Drug Safety
Biomarker Operations Manager - Genmab
Senior Medical Writer with Scientific Focus - Y-mAbs Therapeutics A/S
Senior Drug Substance Specialist - Zealand Pharma
Director Coorporate Drug Safety - Y-mAbs Therapeutics A/S
Global/EU RA Leader - Genmab
Associate Director, GCP QA - Y-mAbs Therapeutics A/S
Clinical Trial Manager - Genmab
Clinical Project Manager – Y-mAbs Therapeutics A/S
Account Manager; Miltenyi Biotec Nordics: Biotech and Pharma
Project Manager/Senior Project Manager – Adding value across the whole value chain - Bavarian Nordic
CMC Project Manager – Process Chemistry
